Tempest Therapeutics (NASDAQ: TPST) experienced a remarkable market upswing of over 2,800%, showcasing one of the most substantial gains this year for a once tiny biotech company trading on the Nasdaq. The surge is undeniably tied to their recent press release. However, decoding the significance of this update can be puzzling for everyday investors who
Nonalcoholic steatohepatitis (NASH) is a massive public health challenge; Sino Biological is currently producing a huge range of NASH related drug targets and reagents.
Milwaukee, WI (PRWEB) November 02, 2022 The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2022,
Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study
Vijay R. Varma , Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing
¶‡ These authors share first authorship on this work.
Affiliation Clinical and Translational Neuroscience Section, Laboratory of Behavioral Neuroscience, National Institute on Aging (NIA), National Institutes of Health (NIH), Baltimore, Maryland, United States of America
¶‡ These authors share first authorship on this work.
Affiliation Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America ⨯
Yang An,